Cargando…

The Value of Pharmacogenomics for White and Indigenous Americans after Kidney Transplantation

Background: There is a paucity of evidence to inform the value of pharmacogenomic (PGx) results in patients after kidney transplant and how these results differ between Indigenous Americans and Whites. This study aims to identify the frequency of recommended medication changes based on PGx results a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brady, Alexandra, Misra, Suman, Abdelmalek, Mina, Kekic, Adrijana, Kunze, Katie, Lim, Elisabeth, Jakob, Nicholas, Mour, Girish, Keddis, Mira T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457738/ https://www.ncbi.nlm.nih.gov/pubmed/37624080 http://dx.doi.org/10.3390/pharmacy11040125

Ejemplares similares

1316. Clinical Utility of Pharmacogenomic Testing in Refractory Coccidioidal Meningitis
por: Blair, Janis E, et al.
Publicado: (2023)

Transplant center assessment of the inequity in the kidney transplant process and outcomes for the Indigenous American patients
por: Keddis, Mira T., et al.
Publicado: (2018)

The pharmacogenomic landscape of an Indigenous Australian population
por: Samarasinghe, Sumudu Rangika, et al.
Publicado: (2023)

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
por: Patrinos, George P., et al.
Publicado: (2023)

The Gene-Drug Duality: Exploring the Pharmacogenomics of Indigenous Populations
por: Nagaraj, Shivashankar H., et al.
Publicado: (2021)

Native American patients’ perception and attitude about kidney transplant: a qualitative assessment of patients presenting for kidney transplant evaluation
por: Keddis, Mira, et al.
Publicado: (2019)

Patient and allograft outcomes after kidney transplant for the Indigenous patients in the United States
por: Seipp, Regan, et al.
Publicado: (2021)

Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis
por: Bolen, Erin, et al.
Publicado: (2021)

State of Art of Cancer Pharmacogenomics in Latin American Populations
por: López-Cortés, Andrés, et al.
Publicado: (2017)

A systematic review of the association between fish oil supplementation and the development of asthma exacerbations
por: Hardy, M Scott, et al.
Publicado: (2016)

Safety and mortality outcomes for direct oral anticoagulants in renal transplant recipients
por: Firth, Christine, et al.
Publicado: (2023)

Pharmacogenomics
Publicado: (2008)

Pharmacogenomics
Publicado: (2008)

The Translational Approaches to Personalized Health Collaborative: Pharmacogenomics for African American Older Adults
por: J Sargent, Lana, et al.
Publicado: (2020)

In search of Pan-American indigenous health and harmony
por: Babyar, Julie
Publicado: (2019)

Pharmacogenomics arrives
por: Petsko, Gregory A
Publicado: (2004)

Pharmacogenomic Biomarkers
por: Kirkwood, Sandra C., et al.
Publicado: (2002)

Pharmacogenomics in epilepsy
por: Balestrini, Simona, et al.
Publicado: (2018)

Pharmacogenomics of Antibiotics
por: Stocco, Gabriele, et al.
Publicado: (2020)

Pharmacogenomics in Practice
por: Wang, Liewei, et al.
Publicado: (2019)

Pharmacogenomics and Morphine
por: Ofoegbu, Adaku, et al.
Publicado: (2021)

GDSCTools for mining pharmacogenomic interactions in cancer
por: Cokelaer, Thomas, et al.
Publicado: (2018)

An objective evaluation of fundamental pharmacogenomics knowledge among pharmacists and pharmacy students
por: Mehtar, Mira, et al.
Publicado: (2022)

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics
por: Mizzi, Clint, et al.
Publicado: (2016)

Translating Pharmacogenomics: Challenges on the Road to the Clinic
por: Swen, Jesse J, et al.
Publicado: (2007)

Renal ablation using bilateral ureteral ligation for nephrotic syndrome due to renal amyloidosis
por: Keddis, Mira T., et al.
Publicado: (2012)

Epidemiology of rheumatic diseases in indigenous populations in Latin-Americans
por: Peláez-Ballestas, Ingris, et al.
Publicado: (2016)

P450 Pharmacogenetics in Indigenous North American Populations
por: Henderson, Lindsay M., et al.
Publicado: (2018)

Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals
por: Trinks, Julieta, et al.
Publicado: (2017)

6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
por: Stojiljkovic, Maja, et al.
Publicado: (2012)

Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics
por: Mizzi, Clint, et al.
Publicado: (2017)

Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis
por: Lim, Sung Ho, et al.
Publicado: (2022)

Inequity and vulnerability in Latin American Indigenous and non-Indigenous populations with rheumatic diseases: a syndemic approach
por: Granados, Ysabel, et al.
Publicado: (2023)

Cytotoxicity and Pharmacogenomics of Medicinal Plants from Traditional Korean Medicine
por: Kuete, Victor, et al.
Publicado: (2013)

Cardiologist Evaluation and Approval Was the Primary Predictor of Kidney Transplant Candidacy and Transplantation Among Patients With Reduced Left Ventricular Ejection Fraction
por: Madden, Michelle, et al.
Publicado: (2023)

Pharmacogenomics: methods and protocols
por: Lai, C
Publicado: (2006)

Pharmacogenomics in depression and antidepressants
por: Bondy, Brigitta
Publicado: (2005)

Clinical use of pharmacogenomics
por: Telenti, Amalio
Publicado: (2012)

Pharmacogenomics: What is Next?
por: di Iulio, Julia, et al.
Publicado: (2012)

Pharmacogenomics of pediatric asthma
por: Gupta, Sarika, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_m6865abcc9fm39lsi1kf8vb0bn